In keeping with virginia mason franciscan healths mission of improving the health of those it serves and especially those who are vulnerable and our commitment to providing safe care for patients and a safe work environment for clinicians and staff virginia mason franciscan health is requiring all employees to be fully vaccinated against covid 19 by hellip.

This phase ii trial studies nivolumab and ipilimumab in treating patients with rare tumors immunotherapy with monoclonal antibodies such as nivolumab and ipilimumab may help the bodys immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread.